Lakewood-Amedex Biotherapeutics shares are trading higher after the company announced resistance data for Nu-3.

Benzinga Newsdesk www.benzinga.com Positive 95.2%

Neg 0% Neu 0% Pos 95.2%

Comments

No comments yet. Be the first!